Fortis Healthcare

802.45
+20.15
(2.58%)
ann
There are 10 new updates from the company20 hours ago
Viewcross
right
Market Cap
60,581.62 Cr
EPS
10.26
PE Ratio
69.81
Dividend Yield
0.13 %
52 Week High
813.00
52 Week Low
475.00
PB Ratio
6.63
Debt to Equity
0.14
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from12 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,257.10
#1 1,22,208.58
107.41
7,184.10
18.77
1,076
26.84
52.84
7,276.50
1,04,624.91
71.75
#1 21,794.00
14.74
1,513
60.41
49.37
802.45
#3 60,581.62
#6 69.81
#2 7,782.75
#10 8.99
#4 809
#9 -7.43
55.03
1,980.70
40,477.74
51.83
5,482.98
10.96
807
3.41
56.50
1,324.50
35,574.40
68.71
3,692.32
#1 25.09
486
-20.35
75.69
602.60
31,221.97
83.76
4,138.46
22.85
#1 5,417
#1 3,986.36
52.92
715.20
28,617.94
75.33
3,035.10
12.94
409
48.39
62.88
6,197.90
16,307.24
#1 32.45
599.90
11.69
58
4.79
57.78
1,536.30
15,601.38
65.27
1,566.90
17.46
244
10.57
55.56
1,493.00
9,789.01
51.74
1,290.20
17.77
194
-0.88
50.32
Forecast
Actual
Growth Rate
Revenue Growth
8.99 %
Net Income Growth
1.93 %
Cash Flow Change
33.79 %
ROE
-3.46 %
ROCE
14.14 %
EBITDA Margin (Avg.)
3.01 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
1,085
1,152
1,150
1,024
1,106
1,176
1,257
1,630
1,164
1,229
1,258
1,175
1,108
1,081
1,156
1,164
1,528
1,170
1,277
1,178
1,133
614
1,029
1,205
1,278
1,733
1,475
1,487
1,391
1,519
1,682
1,586
1,669
1,667
1,788
1,699
1,803
1,873
2,006
1,975
2,032
Expenses
1,022
986
1,087
1,066
1,091
1,059
1,097
1,023
1,045
1,071
1,138
1,069
1,907
1,034
1,172
1,193
1,069
996
1,028
1,012
987
709
875
987
1,055
1,135
1,178
1,180
1,157
1,237
1,304
1,283
1,372
1,386
1,440
1,396
1,405
1,516
1,613
1,553
1,625
EBITDA
62
166
62
-42
15
118
160
607
118
158
120
106
-799
47
-16
-29
459
174
250
166
146
-96
155
218
223
598
297
307
234
282
378
302
297
282
349
303
398
356
393
422
406
Operating Profit %
3 %
4 %
-2 %
-5 %
-2 %
6 %
8 %
10 %
7 %
7 %
5 %
5 %
-76 %
1 %
-3 %
-8 %
10 %
13 %
15 %
13 %
11 %
-17 %
12 %
16 %
16 %
20 %
19 %
20 %
16 %
17 %
19 %
18 %
16 %
16 %
19 %
17 %
21 %
18 %
19 %
19 %
19 %
Depreciation
61
53
0
0
72
48
52
60
63
59
61
59
60
57
56
60
60
71
71
70
80
72
74
73
72
73
75
76
77
74
77
83
82
79
84
87
92
91
95
97
102
Interest
37
34
30
32
38
42
46
75
67
64
66
63
64
76
85
111
65
51
49
48
57
41
42
42
41
38
40
38
30
31
33
33
32
32
32
33
35
35
36
45
68
Profit Before Tax
-22
88
44
-58
-96
28
62
472
-11
35
-7
-17
-924
-87
-157
-201
334
52
130
48
9
-208
38
103
110
486
182
193
126
176
268
186
183
171
233
183
271
230
261
279
237
Tax
-10
-9
-17
-29
-8
3
24
19
26
12
17
3
-9
-34
-15
-20
183
-26
6
118
50
-20
23
49
48
56
51
51
39
42
50
44
45
47
49
49
68
56
68
25
49
Net Profit
-12
97
61
-29
-88
25
38
453
-38
23
-24
-19
-914
-53
-142
-180
151
78
124
-69
-41
-188
16
54
62
431
131
142
87
134
218
142
138
124
184
134
203
174
193
254
188
EPS in ₹
-0.38
2.01
1.19
-0.65
-1.91
0.35
0.68
9.49
-0.79
0.10
-0.88
-0.71
-17.97
-1.36
-3.21
-3.06
1.80
0.90
1.47
-1.01
-0.59
-2.37
-0.05
0.40
0.57
3.49
1.42
1.55
0.90
1.62
2.71
1.72
1.76
1.48
2.30
1.78
2.37
2.20
2.34
3.28
2.44

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
7,616
7,232
9,717
8,622
11,951
11,348
11,155
11,885
12,434
13,289
13,692
Fixed Assets
4,218
3,776
5,419
4,992
8,477
8,802
8,799
9,416
9,426
9,874
6,636
Current Assets
1,636
1,434
1,775
1,282
1,667
941
1,037
1,133
1,406
1,421
1,471
Capital Work in Progress
228
201
268
226
450
204
165
194
228
542
404
Investments
616
1,449
1,878
1,732
270
175
186
104
210
230
115
Other Assets
2,554
1,807
2,152
1,672
2,755
2,167
2,005
2,172
2,569
2,643
0
Total Liabilities
7,616
7,232
9,717
8,622
11,951
11,348
11,155
11,885
12,434
13,289
13,692
Current Liabilities
1,602
1,476
1,927
2,134
3,591
2,579
1,233
1,269
1,426
3,170
1,607
Non Current Liabilities
1,813
1,616
1,480
1,171
1,248
1,563
3,204
3,607
2,907
1,563
2,915
Total Equity
4,201
4,140
6,311
5,317
7,113
7,206
6,718
7,008
8,100
8,556
8,917
Reserve & Surplus
3,585
3,534
4,626
3,543
5,846
5,906
5,365
5,423
6,487
6,908
8,162
Share Capital
463
463
518
519
755
755
755
755
755
755
755

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-66
-38
225
-513
799
-627
212
-153
-22
125
Investing Activities
213
122
-1,001
-333
-3,279
64
-131
-501
-373
-889
Operating Activities
24
195
967
493
-179
172
486
865
822
1,100
Financing Activities
-304
-354
259
-672
4,257
-862
-143
-517
-471
-87

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
26.32 %
0.00 %
23.24 %
23.31 %
25.26 %
26.77 %
27.40 %
DIIs
13.44 %
15.20 %
15.66 %
15.50 %
16.72 %
17.44 %
19.94 %
20.38 %
20.70 %
22.16 %
26.55 %
29.35 %
31.15 %
32.31 %
30.73 %
30.05 %
29.46 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
13.96 %
15.16 %
15.98 %
14.89 %
13.96 %
13.58 %
12.92 %
12.39 %
12.05 %
11.80 %
11.13 %
11.04 %
10.82 %
10.47 %
10.36 %
10.21 %
10.22 %
Others
41.43 %
38.47 %
37.20 %
38.44 %
38.15 %
37.82 %
35.98 %
36.06 %
36.08 %
34.86 %
4.83 %
28.44 %
3.63 %
2.75 %
2.48 %
1.81 %
1.75 %
No of Share Holders
0
1,09,889
1,44,634
1,66,743
1,54,572
1,56,881
1,60,762
1,58,455
1,37,894
1,35,047
1,31,516
1,35,664
1,57,165
1,54,260
2,04,184
2,21,750
2,18,329

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1 1 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.24 0.14 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
11 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
11 Aug 2025 773.45 782.30
20 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
20 May 2025 682.75 685.85
07 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Feb 2025 581.00 651.05
08 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Nov 2024 601.65 623.10
02 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
02 Aug 2024 471.55 505.05
24 Jul 2024 DIVIDEND Dividend
₹ 1.00 /share
24 Jul 2024 469.50 487.45
20 Jul 2023 DIVIDEND Dividend
₹ 1.00 /share
20 Jul 2023 289.05 328.75

Announcements

Letters Contain The Weblink To Access The Annual Report Of Financial Year 2024-2518 hours ago
Announcement under Regulation 30 (LODR)-Dividend Updates18 hours ago
Announcement under Regulation 30 (LODR)-Date of payment of Dividend18 hours ago
Record Date Fixed For Dividend Payment18 hours ago
Please Find Enclosed The Intimation Of Date Of Closure Of Register Of Members & Share Transfer Book18 hours ago
Business Responsibility and Sustainability Reporting (BRSR)20 hours ago
Regulation 53 (1) Annual Report.20 hours ago
Reg. 34 (1) Annual Report.20 hours ago
Intimation Of Notice Of 29Th AGM Of Fortis Healthcare Limited To Be Held On August 11 202521 hours ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 201821 hours ago
Announcement under Regulation 30 (LODR)-Newspaper Publication3 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication3 days ago
Disclosure On Completion Of Term Of Independent DirectorJun 27, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorJun 27, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorJun 27, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateJun 27, 2025
Closure of Trading WindowJun 27, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
Updates On Acquisition - Shrimann HospitalMay 28, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionMay 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2025
Statement Of Utilization And Deviation Or Variation In The Use Of Proceeds Of Issue Of Listed Non-Convertible Debentures (Ncds)May 20, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations).May 20, 2025
Compliance With Respect To The Regulation 56(1)(D) Of SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015 And Other Relevant Provisions.May 20, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 20, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 20, 2025
Compliances-Reg. 54 - Asset Cover details May 20, 2025
Revision In Policies.May 20, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 20, 2025
Appointment Of Secretarial Auditors And Cost Auditors.May 20, 2025
Corporate Action-Board approves DividendMay 20, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 20, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 20, 2025
Outcome Of The Board Meeting Under Regulation 30 33 51(2) And Regulation 52 Of Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations 2015May 20, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 33 51(2) And Regulation 52 Of Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations 2015May 20, 2025
Reschedule Of Investors/ Ananlysts CallMay 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 09, 2025
Board Meeting Intimation for Notice Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 08, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligation & Disclosure Requirements) Regulations 2015May 05, 2025
Disclosure Under Chapter XIV - Centralized Database For Corporate Bonds/ Debentures Of SEBI Master Circular Dated May 22 2024.Apr 30, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 25, 2025
Compliances-Half Yearly Report (SEBI Circular No. CIR/IMD/DF-1/67/2017) Apr 10, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Apr 03, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 03, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderApr 02, 2025

Technical Indicators

RSI(14)
Neutral
55.03
ATR(14)
Volatile
20.26
STOCH(9,6)
Neutral
40.84
STOCH RSI(14)
Oversold
10.30
MACD(12,26)
Bearish
-4.21
ADX(14)
Strong Trend
29.24
UO(9)
Bearish
48.91
ROC(12)
Downtrend And Accelerating
-1.06
WillR(14)
Neutral
-54.97

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Kotak Arbitrage Fund Direct-Growth
0.39%
3366600
0.39%
0.39%
Invesco India Arbitrage Fund Direct-Growth
0.59%
1784825
0.59%
0.59%
Mirae Asset Large & Midcap Fund Direct-Growth
0.00%
-923041
-0.17%
-0.49%
Mirae Asset Midcap Fund Direct - Growth
0.76%
-827482
-0.31%
-0.34%
ICICI Prudential Equity Arbitrage Direct-Growth
0.15%
567300
0.15%
0.15%
Mirae Asset Arbitrage Fund Direct - Growth
0.94%
380525
0.94%
0.94%
Kotak Large & Midcap Fund Direct-Growth
0.84%
300000
0.13%
0.17%
Nippon India Growth Mid Cap Fund Direct- Growth
2.75%
285587
0.21%
0.13%
Nippon India Arbitrage Fund Direct-Growth
0.16%
269700
0.15%
0.16%
Mirae Asset Healthcare Fund Direct - Growth
3.27%
211430
0.82%
1.07%
Aditya Birla Sun Life Multi-Cap Fund Direct-Growth
2.42%
154093
0.33%
0.31%
SBI Arbitrage Opportunities Fund Direct-Growth
0.03%
147250
0.03%
0.03%
Aditya Birla Sun Life Arbitrage Fund Direct-Growth
0.05%
137950
0.05%
0.05%
Tata Nifty Midcap 150 Momentum 50 Index Fund Direct - Growth
2.48%
-111622
-0.72%
-0.79%
Edelweiss Nifty Midcap150 Momentum 50 Index Fund Direct - Growth
2.48%
-103964
-0.71%
-0.80%
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
1.26%
100000
1.26%
1.26%
WhiteOak Capital Mid Cap Fund Direct - Growth
2.05%
86643
0.27%
0.37%
SBI Healthcare Opportunities Fund Direct Plan-Growth
3.30%
-80000
0.08%
0.16%
Bandhan Midcap Fund Direct-Growth
1.14%
68056
0.35%
1.14%
Edelweiss Arbitrage Fund Direct-Growth
0.03%
62775
0.03%
0.03%
Kotak Healthcare Fund Direct - Growth
3.15%
60000
1.20%
1.16%
Nippon India Nifty 500 Momentum 50 Index Fund Direct-Growth
1.91%
-50072
-0.37%
-0.43%
Aditya Birla Sun Life India GenNext Direct Fund-Growth
1.01%
-50000
0.02%
0.04%
Motilal Oswal Nifty 500 Momentum 50 Index Fund Direct-Growth
1.92%
-39528
-0.37%
-0.42%
Baroda BNP Paribas Retirement Fund Direct - Growth
0.71%
35000
0.71%
0.71%

About Fortis Healthcare

Fortis Healthcare Limited is one of India's largest healthcare providers, operating 27 hospitals with 4,500 operational beds and over 426 diagnostics centres as of March 31, 2023. The company offers a wide range of integrated healthcare services including cardiac care, orthopedics, neurosciences, oncology, renal care, gastroenterology, and mother and child care. Fortis uses advanced technology to deliver quality healthcare in modern facilities. Its subsidiary, SRL Limited, is a leading diagnostics chain in India. Fortis Healthcare has a presence in India, Dubai, Mauritius, and Sri Lanka. The company has expanded through acquisitions and new facility launches over the years, focusing on its core Indian market in recent times. It provides inpatient and outpatient services, sells medical and non-medical items, and offers management services to hospitals. Fortis Healthcare's specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, urology, neurosurgery, radiology, orthopedics, and organ transplant.
Listing Date
09 May, 2007(18 Years, 6 days)
Chairperson NameLeo Puri